from

LUMOSA THERAPEUTICS ANNOUNCES POSITIVE RESULTS FROM LT3001(INTRAVENOUS ODATROLTIDE) PHASE 2B CLINICAL TRIAL IN ACUTE ISCHEMIC STROKE

Results presented at the 17th World Stroke Congress (WSC 2025) LT3001(Odatroltide)-202 phase 2b study met primary endpoint. No symptomatic intracranial…

4 months ago

Saudi Arabia Redefines Wealth in Shift From Oil Dependence

RIYADH, Saudi Arabia, Oct. 30, 2025 /PRNewswire/ -- In an analytical article published in Asharq Al-Awsat titled "How is Saudi…

4 months ago

The global campaign ‘7 Wonders of Future Cities’ from New7Wonders starts on World Cities Day

DUBAI, UAE, Oct. 30, 2025 /PRNewswire/ -- New7Wonders, the world's official authority for public voting to choose Wonders, today formally…

4 months ago

Goyaz Secures Series A Investment from Norwest

HYDERABAD, India, Oct. 30, 2025 /PRNewswire/ -- Goyaz, India's fastest-growing occasion-led gold-plated silver jewelry brand, today announced the successful closure of…

4 months ago

Unilumin Establishes Joint Venture, Achieving A Strategic Leap from “Display Hardware Supplier” to “AI Intelligent Service Application Provider”

SHENZHEN, China, Oct. 28, 2025 /PRNewswire/ -- On October 25, 2025, "AI lights up the future "— Unilumin Group's 21st Anniversary…

4 months ago

Two-thirds of surveyed enterprises in EMEA report significant productivity gains from AI, finds new IBM study

66% of responding senior leaders say AI has already driven significant productivity improvements across their organization 41% of respondents anticipate…

4 months ago

Avacta presents first preclinical data from dual payload pre|CISION medicines at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets

First-in-class dual payload peptide drug conjugate delivers two complementary therapies from a single molecule with potential to overcome resistance and…

4 months ago

ACM Biolabs Reports Favorable Safety Signals and Early Pharmacodynamics from Intramuscular Administration of ACM-CpG in Patients with Advanced Solid Tumors

SINGAPORE, Oct. 22, 2025 /PRNewswire/ -- ACM Biolabs, a clinical-stage biotechnology company developing next-generation nanoparticle-based immunotherapies, today announced encouraging early clinical findings…

4 months ago

ITM Announces Analyses from Phase 3 COMPETE Data Showing Higher Objective Response Rates with n.c.a. 177Lu-edotreotide (ITM-11) vs. Everolimus Across Subgroups of Patients with GEP-NETs at NANETS 2025 Annual Symposium

Austin, Texas, October 25, 2025 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, announced analyses data…

4 months ago

From Grandstand to Every Person: Sting Makes F1 Dream a Reality for Fans

In a bold move that fuses cinema, culture, and adrenaline, Sting® Energy, PepsiCo India’s high-voltage energy drink, has dialled up…

4 months ago